Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

The IgG2 isotype of anti-transcription intermediary factor 1-gamma autoantibodies is a biomarker of mortality in adult dermatomyositis.

Aussy A, Fréret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Fabienne J, Joly P, Isabelle M, Meyer A, Sibilia J, Bader-Meunier B, Hachulla E, Hamidou M, Huë S, Charuel JL, Fabien N, Viailly PJ, Allenbach Y, Benveniste O, Cordel N, Boyer O; OncoMyositis study group.

Arthritis Rheumatol. 2019 Mar 21. doi: 10.1002/art.40895. [Epub ahead of print]

PMID:
30896088
2.

Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation.

Nguyen LS, Vautier M, Allenbach Y, Zahr N, Benveniste O, Funck-Brentano C, Salem JE.

Drug Saf. 2019 Mar 13. doi: 10.1007/s40264-019-00810-9. [Epub ahead of print] Review.

PMID:
30868436
3.

Comparison of MR T1 and T2 mapping parameters to characterize myocardial and skeletal muscle involvement in systemic idiopathic inflammatory myopathy (IIM).

Huber AT, Lamy J, Bravetti M, Bouazizi K, Bacoyannis T, Roux C, De Cesare A, Rigolet A, Benveniste O, Allenbach Y, Kerneis M, Cluzel P, Redheuil A, Kachenoura N.

Eur Radiol. 2019 Mar 7. doi: 10.1007/s00330-019-06054-6. [Epub ahead of print]

PMID:
30847587
4.

Autoantibody testing in idiopathic inflammatory myopathies.

Rietveld A, Lim J, de Visser M, van Engelen B, Pruijn G, Benveniste O, van der Kooi A, Saris C.

Pract Neurol. 2019 Mar 2. pii: practneurol-2017-001742. doi: 10.1136/practneurol-2017-001742. [Epub ahead of print] Review.

PMID:
30826741
5.

CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis.

Dzangué-Tchoupou G, Mariampillai K, Bolko L, Amelin D, Mauhin W, Corneau A, Blanc C, Allenbach Y, Benveniste O.

Autoimmun Rev. 2019 Feb 28. pii: S1568-9972(19)30029-1. doi: 10.1016/j.autrev.2019.02.003. [Epub ahead of print] Review.

PMID:
30825520
6.

Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.

Allenbach Y, Bolko L, Toquet S, Landon-Cardinal O, Benveniste O.

Brain. 2019 Mar 1;142(3):e9. doi: 10.1093/brain/awz006. No abstract available.

PMID:
30715158
7.

Responsiveness to Change of 5-point MRC scale, Endurance and Functional Evaluation for Assessing Myositis in Daily Clinical Practice.

Landon-Cardinal O, Devilliers H, Chavarot N, Mariampillai K, Rigolet A, Hervier B, Allenbach Y, Benveniste O.

J Neuromuscul Dis. 2019;6(1):99-107. doi: 10.3233/JND-180358.

PMID:
30714969
8.

Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.

Anquetil C, Boyer O, Wesner N, Benveniste O, Allenbach Y.

Autoimmun Rev. 2019 Mar;18(3):223-230. doi: 10.1016/j.autrev.2018.09.008. Epub 2019 Jan 11. Review.

PMID:
30639649
9.

French expert opinion for the management of juvenile dermatomyositis.

Bader-Meunier B, Gitiaux C, Belot A, Brochard K, Mouy R, Ponce D, Bughin V, Jouen F, Musset L, Allenbach Y, Hachulla E, Maillard H, Meyer A, Bourrat E, Benveniste O; French Network of rare autoimmune, autoinflammatory diseases FAI2R.

Arch Pediatr. 2019 Feb;26(2):120-125. doi: 10.1016/j.arcped.2018.12.002. Epub 2019 Jan 10.

PMID:
30638764
10.

Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease.

Mauhin W, Lidove O, Benveniste O.

Orphanet J Rare Dis. 2019 Jan 7;14(1):4. doi: 10.1186/s13023-018-0979-z.

11.

Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy.

Mohassel P, Landon-Cardinal O, Foley AR, Donkervoort S, Pak KS, Wahl C, Shebert RT, Harper A, Fequiere P, Meriggioli M, Toro C, Drachman D, Allenbach Y, Benveniste O, Béhin A, Eymard B, Lafôret P, Stojkovic T, Mammen AL, Bönnemann CG.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 12;6(1):e523. doi: 10.1212/NXI.0000000000000523. eCollection 2019 Jan.

12.

Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy.

Landon-Cardinal O, Allenbach Y, Soulages A, Rigolet A, Hervier B, Champtiaux N, Monzani Q, Solé G, Benveniste O.

J Rheumatol. 2018 Dec 15. pii: jrheum.171495. doi: 10.3899/jrheum.171495. [Epub ahead of print]

PMID:
30554155
13.

Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE.

Galeotti C, Stephen-Victor E, Karnam A, Das M, Gilardin L, Maddur MS, Wymann S, Vonarburg C, Chevailler A, Dimitrov JD, Benveniste O, Bruhns P, Kaveri SV, Bayry J.

J Allergy Clin Immunol. 2018 Dec 7. pii: S0091-6749(18)31733-0. doi: 10.1016/j.jaci.2018.10.064. [Epub ahead of print]

PMID:
30529242
14.

Immune Checkpoint Inhibitor-Associated Myositis.

Anquetil C, Salem JE, Lebrun-Vignes B, Johnson DB, Mammen AL, Stenzel W, Léonard-Louis S, Benveniste O, Moslehi JJ, Allenbach Y.

Circulation. 2018 Aug 14;138(7):743-745. doi: 10.1161/CIRCULATIONAHA.118.035898. No abstract available.

PMID:
30359135
15.

Reply: A child with severe juvenile dermatomyositis treated with ruxolitinib.

Allenbach Y, Toquet S, Landon-Cardinal O, Benveniste O.

Brain. 2018 Nov 1;141(11):e81. doi: 10.1093/brain/awy256. No abstract available.

PMID:
30335129
16.

Dermoskeletics to preserve mobility and function in inclusion body myositis.

Landon-Cardinal O, Prince F, Bédard S, Benveniste O, Hudson M.

Neurology. 2018 Oct 16;91(16):760. doi: 10.1212/WNL.0000000000006365. No abstract available.

PMID:
30323070
17.

In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy.

Bergua C, Chiavelli H, Allenbach Y, Arouche-Delaperche L, Arnoult C, Bourdenet G, Jean L, Zoubairi R, Guerout N, Mahler M, Benveniste O, Drouot L, Boyer O.

Ann Rheum Dis. 2019 Jan;78(1):131-139. doi: 10.1136/annrheumdis-2018-213518. Epub 2018 Oct 11.

PMID:
30309969
18.

Diagnostic potential of sarcoplasmic MxA expression in subsets of dermatomyositis.

Uruha A, Allenbach Y, Charuel JL, Musset L, Aussy A, Boyer O, Mariampillai K, Landon-Cardinal O, Rasmussen C, Bolko L, Maisonobe T, Leonard-Louis S, Suzuki S, Nishino I, Stenzel W, Benveniste O.

Neuropathol Appl Neurobiol. 2018 Sep 28. doi: 10.1111/nan.12519. [Epub ahead of print]

PMID:
30267437
19.

Peculiar clinicopathological features of immune-mediated necrotizing myopathies.

Allenbach Y, Benveniste O.

Curr Opin Rheumatol. 2018 Nov;30(6):655-663. doi: 10.1097/BOR.0000000000000547.

PMID:
30239349
20.

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.

Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, Meyer A, Tohmé A, Charuel JL, Musset L, Allenbach Y, Benveniste O.

JAMA Neurol. 2018 Dec 1;75(12):1528-1537. doi: 10.1001/jamaneurol.2018.2598.

PMID:
30208379
21.

Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol.

Lorenzon R, Mariotti-Ferrandiz E, Aheng C, Ribet C, Toumi F, Pitoiset F, Chaara W, Derian N, Johanet C, Drakos I, Harris S, Amselem S, Berenbaum F, Benveniste O, Bodaghi B, Cacoub P, Grateau G, Amouyal C, Hartemann A, Saadoun D, Sellam J, Seksik P, Sokol H, Salem JE, Vicaut E, Six A, Rosenzwajg M, Bernard C, Klatzmann D.

BMJ Open. 2018 Aug 30;8(8):e021037. doi: 10.1136/bmjopen-2017-021037.

22.

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer.

Touat M, Maisonobe T, Knauss S, Ben Hadj Salem O, Hervier B, Auré K, Szwebel TA, Kramkimel N, Lethrosne C, Bruch JF, Laly P, Cadranel J, Weiss N, Béhin A, Allenbach Y, Benveniste O, Lenglet T, Psimaras D, Stenzel W, Léonard-Louis S.

Neurology. 2018 Sep 4;91(10):e985-e994. doi: 10.1212/WNL.0000000000006124. Epub 2018 Aug 8.

PMID:
30089619
23.

Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.

Ladislau L, Arouche-Delaperche L, Allenbach Y, Benveniste O.

Curr Rheumatol Rep. 2018 Aug 3;20(9):56. doi: 10.1007/s11926-018-0763-z. Review.

PMID:
30074107
24.

Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY.

Mauhin W, Lidove O, Amelin D, Lamari F, Caillaud C, Mingozzi F, Dzangué-Tchoupou G, Arouche-Delaperche L, Douillard C, Dussol B, Leguy-Seguin V, D'Halluin P, Noel E, Zenone T, Matignon M, Maillot F, Ly KH, Besson G, Willems M, Labombarda F, Masseau A, Lavigne C, Froissart R, Lacombe D, Ziza JM, Hachulla E, Benveniste O.

Orphanet J Rare Dis. 2018 Jul 31;13(1):127. doi: 10.1186/s13023-018-0877-4.

25.

Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis.

Landon-Cardinal O, Friedman D, Guiguet M, Laforêt P, Heming N, Salort-Campana E, Jouen F, Allenbach Y, Boyer O, Chatenoud L, Eymard B, Sharshar T, Benveniste O.

J Neuromuscul Dis. 2018;5(2):241-249. doi: 10.3233/JND-180300.

PMID:
29865089
26.

Symptomatic muscular sarcoidosis: Lessons from a nationwide multicenter study.

Cohen Aubart F, Abbara S, Maisonobe T, Cottin V, Papo T, Haroche J, Mathian A, Pha M, Gilardin L, Hervier B, Soussan M, Morlat P, Nunes H, Benveniste O, Amoura Z, Valeyre D.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 16;5(3):e452. doi: 10.1212/NXI.0000000000000452. eCollection 2018 May.

27.

Activated dendritic cells modulate proliferation and differentiation of human myoblasts.

Ladislau L, Portilho DM, Courau T, Solares-Pérez A, Negroni E, Lainé J, Klatzmann D, Bonomo A, Allenbach Y, Benveniste O, Riederer I, Savino W, Mouly V, Butler-Browne G, Benjamim CF.

Cell Death Dis. 2018 May 1;9(5):551. doi: 10.1038/s41419-018-0426-z.

28.

JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.

Ladislau L, Suárez-Calvet X, Toquet S, Landon-Cardinal O, Amelin D, Depp M, Rodero MP, Hathazi D, Duffy D, Bondet V, Preusse C, Bienvenu B, Rozenberg F, Roos A, Benjamim CF, Gallardo E, Illa I, Mouly V, Stenzel W, Butler-Browne G, Benveniste O, Allenbach Y.

Brain. 2018 Jun 1;141(6):1609-1621. doi: 10.1093/brain/awy105.

PMID:
29741608
29.

Muscle Shear Wave Elastography in Inclusion Body Myositis: Feasibility, Reliability and Relationships with Muscle Impairments.

Bachasson D, Dubois GJR, Allenbach Y, Benveniste O, Hogrel JY.

Ultrasound Med Biol. 2018 Jul;44(7):1423-1432. doi: 10.1016/j.ultrasmedbio.2018.03.026. Epub 2018 Apr 26.

30.

Analysis of cell surface and intranuclear markers on non-stimulated human PBMC using mass cytometry.

Dzangué-Tchoupou G, Corneau A, Blanc C, Benveniste O, Allenbach Y.

PLoS One. 2018 Mar 22;13(3):e0194593. doi: 10.1371/journal.pone.0194593. eCollection 2018.

31.

Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis.

Radke J, Koll R, Preuße C, Pehl D, Todorova K, Schönemann C, Allenbach Y, Aronica E, de Visser M, Heppner FL, Weis J, Doostkam S, Maisonobe T, Benveniste O, Goebel HH, Stenzel W.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 6;5(3):e451. doi: 10.1212/NXI.0000000000000451. eCollection 2018 May.

32.

Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping.

Huber AT, Bravetti M, Lamy J, Bacoyannis T, Roux C, de Cesare A, Rigolet A, Benveniste O, Allenbach Y, Kerneis M, Cluzel P, Kachenoura N, Redheuil A.

J Cardiovasc Magn Reson. 2018 Feb 12;20(1):11. doi: 10.1186/s12968-018-0430-6.

33.

Local Texture Anisotropy as an Estimate of Muscle Quality in Ultrasound Imaging.

Dubois GJR, Bachasson D, Lacourpaille L, Benveniste O, Hogrel JY.

Ultrasound Med Biol. 2018 May;44(5):1133-1140. doi: 10.1016/j.ultrasmedbio.2017.12.017. Epub 2018 Feb 7.

34.

Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement.

Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N, Mariampillai K, Rigolet A, Hufnagl P, Zerbe N, Amelin D, Maisonobe T, Louis-Leonard S, Duyckaerts C, Eymard B, Goebel HH, Bergua C, Drouot L, Boyer O, Benveniste O, Stenzel W.

Neurology. 2018 Feb 6;90(6):e507-e517. doi: 10.1212/WNL.0000000000004923. Epub 2018 Jan 12.

PMID:
29330311
35.

Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al.

Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Jordan P, Benveniste O, Danieli MG, Dankó K, Phuong Thuy NT, Vázquez-Del Mercado M, Andersson H, Paepe B, De Bleecker JL, Maurer B, McCann LJ, Pipitone N, McHugh N, Betteridge Z, New P, Cooper RG, Ollier WE, Lamb JA, Krogh NS, Lundberg IE, Chinoy H; all EuroMyositis contributors.

Ann Rheum Dis. 2018 Aug;77(8):e51. doi: 10.1136/annrheumdis-2017-212382. Epub 2017 Dec 19. No abstract available.

PMID:
29259048
36.

224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016.

Allenbach Y, Mammen AL, Benveniste O, Stenzel W; Immune-Mediated Necrotizing Myopathies Working Group.

Neuromuscul Disord. 2018 Jan;28(1):87-99. doi: 10.1016/j.nmd.2017.09.016. Epub 2017 Oct 23. No abstract available.

PMID:
29221629
37.

[Focal myositis: An unknown disease].

Gallay L, Streichenberger N, Benveniste O, Allenbach Y.

Rev Med Interne. 2017 Oct;38(10):679-684. doi: 10.1016/j.revmed.2017.06.015. Epub 2017 Sep 22. Review. French.

PMID:
28947258
38.

The EuroMyositis registry: an international collaborative tool to facilitate myositis research.

Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Oakley P, Benveniste O, Danieli MG, Danko K, Thuy NTP, Vazquez-Del Mercado M, Andersson H, De Paepe B, deBleecker JL, Maurer B, McCann LJ, Pipitone N, McHugh N, Betteridge ZE, New P, Cooper RG, Ollier WE, Lamb JA, Krogh NS, Lundberg IE, Chinoy H; all EuroMyositis contributors.

Ann Rheum Dis. 2018 Jan;77(1):30-39. doi: 10.1136/annrheumdis-2017-211868. Epub 2017 Aug 30.

39.

Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance.

Uruha A, Benveniste O.

Curr Opin Neurol. 2017 Oct;30(5):457-463. doi: 10.1097/WCO.0000000000000477. Review.

PMID:
28678037
40.

IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis.

Meyer A, Laverny G, Allenbach Y, Grelet E, Ueberschlag V, Echaniz-Laguna A, Lannes B, Alsaleh G, Charles AL, Singh F, Zoll J, Lonsdorfer E, Maurier F, Boyer O, Gottenberg JE, Nicot AS, Laporte J, Benveniste O, Metzger D, Sibilia J, Geny B.

Acta Neuropathol. 2017 Oct;134(4):655-666. doi: 10.1007/s00401-017-1731-9. Epub 2017 Jun 16.

PMID:
28623559
41.

Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies.

Bachasson D, Landon-Cardinal O, Benveniste O, Hogrel JY, Allenbach Y.

Neurology. 2017 Jul 4;89(1):101-103. doi: 10.1212/WNL.0000000000004061. Epub 2017 May 31. No abstract available.

PMID:
28566549
42.

[A complex case of diabetes due to LMNA mutation].

Ambonville C, Bouldouyre MA, Laforêt P, Richard P, Benveniste O, Vigouroux C.

Rev Med Interne. 2017 Oct;38(10):695-699. doi: 10.1016/j.revmed.2017.04.006. Epub 2017 May 23. French.

PMID:
28545855
43.

Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies.

Mauhin W, Mariampillai K, Allenbach Y, Charuel JL, Musset L, Benveniste O.

Joint Bone Spine. 2018 May;85(3):375-376. doi: 10.1016/j.jbspin.2017.04.004. Epub 2017 Apr 20. No abstract available.

PMID:
28435082
44.

Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.

Arouche-Delaperche L, Allenbach Y, Amelin D, Preusse C, Mouly V, Mauhin W, Tchoupou GD, Drouot L, Boyer O, Stenzel W, Butler-Browne G, Benveniste O.

Ann Neurol. 2017 Apr;81(4):538-548. doi: 10.1002/ana.24902.

PMID:
28224701
45.

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

Lilleker JB, Rietveld A, Pye SR, Mariampillai K, Benveniste O, Peeters MT, Miller JA, Hanna MG, Machado PM, Parton MJ, Gheorghe KR, Badrising UA, Lundberg IE, Sacconi S, Herbert MK, McHugh NJ, Lecky BR, Brierley C, Hilton-Jones D, Lamb JA, Roberts ME, Cooper RG, Saris CG, Pruijn GJ, Chinoy H, van Engelen BG; all UKMYONET contributors.

Ann Rheum Dis. 2017 May;76(5):862-868. doi: 10.1136/annrheumdis-2016-210282. Epub 2017 Jan 25.

46.

Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.

Rothwell S, Cooper RG, Lundberg IE, Gregersen PK, Hanna MG, Machado PM, Herbert MK, Pruijn GJM, Lilleker JB, Roberts M, Bowes J, Seldin MF, Vencovsky J, Danko K, Limaye V, Selva-O'Callaghan A, Platt H, Molberg Ø, Benveniste O, Radstake TRDJ, Doria A, De Bleecker J, De Paepe B, Gieger C, Meitinger T, Winkelmann J, Amos CI, Ollier WE, Padyukov L, Lee AT, Lamb JA, Chinoy H; Myositis Genetics Consortium.

Arthritis Rheumatol. 2017 May;69(5):1090-1099. doi: 10.1002/art.40045. Epub 2017 Apr 4.

47.

Resistant myasthenia gravis and rituximab: A monocentric retrospective study of 28 patients.

Afanasiev V, Demeret S, Bolgert F, Eymard B, Laforêt P, Benveniste O.

Neuromuscul Disord. 2017 Mar;27(3):251-258. doi: 10.1016/j.nmd.2016.12.004. Epub 2016 Dec 14.

PMID:
28082209
48.

Integrated classification of inflammatory myopathies.

Allenbach Y, Benveniste O, Goebel HH, Stenzel W.

Neuropathol Appl Neurobiol. 2017 Feb;43(1):62-81. doi: 10.1111/nan.12380. Review.

PMID:
28075491
49.

Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy.

Belhomme N, Maamar A, Le Gallou T, Minot-Myhié MC, Larralde A, Champtiaux N, Benveniste O, Leonard-Louis S, Decaux O, Lescoat A, Le Tulzo Y.

Ann Hematol. 2017 Apr;96(4):695-696. doi: 10.1007/s00277-016-2916-3. Epub 2017 Jan 5. No abstract available.

50.

Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA.

Price MA, Barghout V, Benveniste O, Christopher-Stine L, Corbett A, de Visser M, Hilton-Jones D, Kissel JT, Lloyd TE, Lundberg IE, Mastaglia F, Mozaffar T, Needham M, Schmidt J, Sivakumar K, DeMuro C, Tseng BS.

J Neuromuscul Dis. 2016 Mar 3;3(1):67-75.

Supplemental Content

Loading ...
Support Center